Skip to main navigation Skip to search Skip to main content

Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration

  • Daniel F. Martin
  • , Michael Klein
  • , Julia Haller
  • , Anthony Adamis
  • , Evangelos Gragoudas
  • , Joan Miller
  • , Mark Blumenkrantz
  • , Morton Goldberg
  • , Lawrence Yannuzzi
  • , Dwight Henninger
  • , Laurie B. Wiegand
  • , Long Shiuh Chen
  • , Daniel W. Drolet
  • , Stanley C. Gill
  • , Jerry Bill
  • , Blake Tomkinson
  • , R. A. Bendele
  • , Denis O'Shaughnessy
  • , David R. Guyer
  • , Samir Patel

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science